These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Induction of experimental allergic arthritis with outer surface proteins of Borrelia burgdorferi. Gondolf KB; Mihatsch M; Curschellas E; Dunn JJ; Batsford SR Arthritis Rheum; 1994 Jul; 37(7):1070-7. PubMed ID: 8024615 [TBL] [Abstract][Full Text] [Related]
6. A fusion product of the complete Borrelia burgdorferi outer surface protein A (OspA) and the hepatitis B virus capsid protein is highly immunogenic and induces protective immunity similar to that seen with an effective lipidated OspA vaccine formula. Nassal M; Skamel C; Kratz PA; Wallich R; Stehle T; Simon MM Eur J Immunol; 2005 Feb; 35(2):655-65. PubMed ID: 15668917 [TBL] [Abstract][Full Text] [Related]
7. Molecular characterization of the OspA(161-175) T cell epitope associated with treatment-resistant Lyme arthritis: differences among the three pathogenic species of Borrelia burgdorferi sensu lato. Drouin EE; Glickstein LJ; Steere AC J Autoimmun; 2004 Nov; 23(3):281-92. PubMed ID: 15501399 [TBL] [Abstract][Full Text] [Related]
8. Borrelia burgdorferi outer surface protein A (OspA) activates and primes human neutrophils. Morrison TB; Weis JH; Weis JJ J Immunol; 1997 May; 158(10):4838-45. PubMed ID: 9144499 [TBL] [Abstract][Full Text] [Related]
9. Selective association of outer surface lipoproteins with the lipid rafts of Borrelia burgdorferi. Toledo A; Crowley JT; Coleman JL; LaRocca TJ; Chiantia S; London E; Benach JL mBio; 2014 Mar; 5(2):e00899-14. PubMed ID: 24618252 [TBL] [Abstract][Full Text] [Related]
10. Expression of truncated and full-length forms of the Lyme disease Borrelia outer surface protein A in Escherichia coli. Hansson L; Noppa L; Nilsson AK; Strömqvist M; Bergström S Protein Expr Purif; 1995 Feb; 6(1):15-24. PubMed ID: 7756835 [TBL] [Abstract][Full Text] [Related]
11. Development of hepatitis B virus capsids into a whole-chain protein antigen display platform: new particulate Lyme disease vaccines. Nassal M; Skamel C; Vogel M; Kratz PA; Stehle T; Wallich R; Simon MM Int J Med Microbiol; 2008 Jan; 298(1-2):135-42. PubMed ID: 17888729 [TBL] [Abstract][Full Text] [Related]
12. Structure-based design of a second-generation Lyme disease vaccine based on a C-terminal fragment of Borrelia burgdorferi OspA. Koide S; Yang X; Huang X; Dunn JJ; Luft BJ J Mol Biol; 2005 Jul; 350(2):290-9. PubMed ID: 15935380 [TBL] [Abstract][Full Text] [Related]
13. Analysis of the lipidated recombinant outer surface protein A from Borrelia burgdorferi by mass spectrometry. Bouchon B; Klein M; Bischoff R; Van Dorsselaer A; Roitsch C Anal Biochem; 1997 Mar; 246(1):52-61. PubMed ID: 9056182 [TBL] [Abstract][Full Text] [Related]
14. Comparison of different Borrelia burgdorferi sensu lato strains for detection of immune response in patients with erythema migrans. Merljak Skocir L; Ruzić-Sabljić E; Maraspin-Carman V; Lotric-Furlan S; Logar M; Strle F Int J Med Microbiol; 2008 Jul; 298(5-6):493-504. PubMed ID: 17892971 [TBL] [Abstract][Full Text] [Related]